共 50 条
- [11] PHARMACOKINETICS OF 4'EPI-ADRIAMYCIN AFTER MORNING AND AFTERNOON INTRAVENOUS ADMINISTRATION MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1989, 6 (03): : 195 - 197
- [14] LACK OF MUTAGENICITY BY DOXORUBICIN, 4'-EPI-DOXORUBICIN AND 4'-DEOXYDOXORUBICIN IN HUMAN-CELLS EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (09): : 1284 - 1284
- [16] PHASE-II TRIAL OF 4'-EPI-DOXORUBICIN IN METASTATIC MELANOMA CANCER TREATMENT REPORTS, 1984, 68 (12): : 1509 - 1510
- [17] PHASE-II CLINICAL-EVALUATION OF 4'-EPI-DOXORUBICIN CANCER TREATMENT REPORTS, 1983, 67 (04): : 337 - 341
- [18] Inhibition of NO synthase induction by an anticancer drug 4'-epi-doxorubicin in rats GENERAL PHARMACOLOGY, 1996, 27 (08): : 1367 - 1372
- [19] ACTIVITY OF 4'-EPI-DOXORUBICIN ON NORMAL HEMATOPOIETIC PRECURSOR CELLS IN MICE CANCER TREATMENT REPORTS, 1982, 66 (12): : 2061 - 2070
- [20] 4'-EPI-DOXORUBICIN IN COMBINATION WITH CISPLATIN IN ADVANCED OVARIAN-CANCER CANCER TREATMENT REPORTS, 1984, 68 (11): : 1391 - 1393